🔗 Permalink

Inventor profile of:

Lijun WU

City:

Albany, California

Country:

United States

Published Applications:

Last publication date:

2025-11-06

Top Assignees for applications by Lijun WU

The entities that hold a legal rights for patent applications filed by inventor WU Lijun:

ProMab Biotechnologies, Inc. 11 Richmond, CA United States
Forevertek Biotechnology Co., Ltd 10 Changsha, China
Caribou Biosciences, Inc. 8 Berkeley, CA United States
The General Hospital Corporation 1 Boston, MA United States
HUNAN EHOME HEALTH TECHNOLOGY COMPANY LIMITED 1 Changsha, China
Forevertek Biotechnology Co., Ltd. 1 Hunan, China

Recent patent applications by WU Lijun

Lijun WU from Albany, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-06

US20250339465A1

Human necessities

ANTI-ROR1 ANTIBODY AND ROR1-TARGETING ENGINEERED CELLS

#2 | 2024-07-18

US20240239918A1

Chemistry; metallurgy

ANTI-ROR1 ANTIBODY AND ROR1-TARGETING ENGINEERED CELLS

#3 | 2023-11-30

US20230383009A1

Chemistry; metallurgy

Anti-ROR1 antibody and ROR1-targeting engineered cells

#4 | 2023-11-30

US20230383002A1

Chemistry; metallurgy

Humanized BCMA antibody and BCMA-CAR-T cells

#5 | 2023-09-28

US20230303708A1

Chemistry; metallurgy

HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS

#6 | 2023-09-21

US20230295331A1

Chemistry; metallurgy

CS1- ANTIBODY AND ANTI-CS1-CAR-T CELLS

#7 | 2023-09-07

US20230279140A1

Chemistry; metallurgy

HUMANIZED CD37 AND Bl-SPECIFIC CD19-HUMANIZED CD37 CAR-T CELLS

#8 | 2023-07-20

US20230227557A1

Chemistry; metallurgy

PD-L1-SPECIFIC ANTIBODY AND ANTI-PD-L1-CAR-T CELLS

#9 | 2022-11-10

US20220356262A1

Chemistry; metallurgy

HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS

#10 | 2022-11-03

US20220348688A1

Chemistry; metallurgy

PLAP-CD3 EPSILON BISPECIFIC ANTIBODIES

#11 | 2022-07-14

US20220220217A1

Chemistry; metallurgy

Humanized BCMA antibody and BCMA-CAR-T cells

#12 | 2022-07-14

US20220220201A1

Chemistry; metallurgy

CS1 ANTIBODY AND ANTI-CS1-CAR-T CELLS

#13 | 2022-01-20

US20220017633A1

Chemistry; metallurgy

Humanized BCMA antibody and BCMA-CAR-T cells

#14 | 2021-12-23

US20210395364A1

Chemistry; metallurgy

CAR-T cells with humanized CD19 ScFv

#15 | 2021-11-11

US20210347909A1

Chemistry; metallurgy

Epcam antibody and Epcam-CAR-T cells

#16 | 2021-11-04

US20210340271A1

Chemistry; metallurgy

CD37-ANTIBODY AND CD37-CAR-T CELLS

#17 | 2021-09-09

US20210277136A1

Chemistry; metallurgy

BCMA-CAR-natural killer (NK) cells and methods related thereto

#18 | 2021-05-27

US20210155704A1

Chemistry; metallurgy

Humanized BCMA antibody and BCMA-CAR-T cells

#19 | 2021-04-15

US20210107996A1

Chemistry; metallurgy

PLAP-CAR-effector cells

#20 | 2021-01-21

US20210015870A1

Human necessities

BCMA-CAR-T cells

#21 | 2020-12-24

US20200399387A1

Chemistry; metallurgy

Humanized BCMA antibody and BCMA-CAR-T cells

#22 | 2020-11-12

US20200354451A1

Chemistry; metallurgy

Chimeric antigen receptors comprising a human transferrin epitope sequence

#23 | 2020-06-18

US20200190163A1

Chemistry; metallurgy

HUMANIZED BCMA-CAR-T CELLS

#24 | 2019-11-07

US20190338028A1

Chemistry; metallurgy

CD47-CAR-T cells

#25 | 2019-06-13

US20190177398A1

Chemistry; metallurgy

Chimeric antigen receptors having GITR intracellular domain as co-stimulatory domain

#26 | 2019-02-28

US20190062430A1

Chemistry; metallurgy

Flag tagged CD19-CAR-T cells

#27 | 2019-01-24

US20190023764A1

Chemistry; metallurgy

CAR HAVING REPLICATED BINDING MOTIFS IN A CO-STIMULATORY DOMAIN

#28 | 2019-01-17

US20190015493A1

Human necessities

ADHERENT CANCER CELL LINE EXPRESSING A HEMATOLOGICAL TUMOR ANTIGEN

#29 | 2017-12-07

US20170348403A1

Human necessities

Adherent cancer cell line expressing a hematological tumor antigen

#30 | 2016-12-29

US20160381265A1

Electricity

Cassette attachment device for detecting intensity of test strip cassette

InventorID:

1752896 ⎘